IDH1 and central nervous system cancer: Mutation frequencies ranged from 3% to 10%, with higher rates in 1p/19q codeleted and IDH-mutant oligodendrogliomas and IDH-wildtype astrocytomas (10%), and lower frequencies in GBM IDH-wildtype (3%), the most aggressive glioma subtype.